Publications

Saric J, Bolz M, Waser M, Käser M. The consequences of compromising the EU's free movement of persons principle on Swiss research: how to survive constrained access to regional funding. Health Res Policy Syst. 2021;19:30. DOI: 10.1186/s12961-021-00684-3

Vandelannoote K, Pluschke G, Bolz M, Bratschi M.W, Kerber S, Stinear T.P, de Jong B.C. Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mapé river. PLoS Negl Trop Dis. 2020;14(9):e0008501. DOI: 10.1371/journal.pntd.0008501

Bolz M, Ruf M.T. Buruli ulcer in animals and experimental infection models. In: Pluschke G,Röltgen K, eds. Buruli ulcer: , 159-182. Cham: Springer, 2019. DOI: 10.1007/978-3-030-11114-4_9

Ruf M.T, Steffen C, Bolz M, Schmid P, Pluschke G. Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria. Virulence. 2017;8(8):1918-1926. DOI: 10.1080/21505594.2017.1370530

Bieri R, Bolz M, Ruf M.T, Pluschke G. Interferon-gamma is a crucial activator of early host immune defense against Mycobacterium ulcerans infection in mice. PLoS Negl Trop Dis. 2016;10(2):e0004450. DOI: 10.1371/journal.pntd.0004450

Bolz M, Bénard A, Dreyer A.M, Kerber S, Vettiger A, Oehlmann W, Singh M, Duthie M.S, Pluschke G. Vaccination with the surface proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans induces antibodies but fails to provide protection against Buruli ulcer. PLoS Negl Trop Dis. 2016;10(2):e0004431. DOI: 10.1371/journal.pntd.0004431

Bolz M, Ruggli N, Borel N, Pluschke G, Ruf M.T. Local cellular immune responses and pathogenesis of Buruli ulcer lesions in the experimental Mycobacterium ulcerans pig infection model. PLoS Negl Trop Dis. 2016;10(4):e0004678. DOI: 10.1371/journal.pntd.0004678

Ruf M.T, Bolz M, Vogel M, Bayi P.F, Bratschi M.W, Sopho G.E, Yeboah-Manu D, Um Boock A, Junghanss T, Pluschke G. Spatial distribution of Mycobacterium ulcerans in Buruli ulcer lesions: implications for laboratory diagnosis. PLoS Negl Trop Dis. 2016;10(6):e0004767. DOI: 10.1371/journal.pntd.0004767

Vogel M, Bayi P.F, Ruf M.T, Bratschi M.W, Bolz M, Um Boock A, Zwahlen M, Pluschke G, Junghanss T. Local heat application for the treatment of Buruli ulcer: results of a phase II open label single center non comparative clinical trial. Clin Infect Dis. 2016;62(3):342-350. DOI: 10.1093/cid/civ883

Andreoli A, Bratschi M.W, Bolz M, Minyem J.C, Grize L, Wantong F.G, Kerber S, Tabah E.N, Ruf M.T, Mou F, Noumen D, Boock A.U, Pluschke G. Epidemiology of Buruli ulcer in the Mape Dam region of Cameroon: a longitudinal study. Trop Med Int Health, 2015;20(Suppl. 1):245. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

Bolz M, Bratschi M.W, Kerber S, Minyem J.C, Um Boock A, Vogel M, Bayi P.F, Junghanss T, Brites D, Harris S.R, Parkhill J, Pluschke G, Lamelas Cabello A. Locally confined clonal complexes of Mycobacterium ulcerans in two Buruli ulcer endemic regions of Cameroon. PLoS Negl Trop Dis. 2015;9(6):e0003802. DOI: 10.1371/journal.pntd.0003802

Bolz M, Kerber S, Zimmer G, Pluschke G. Use of recombinant virus replicon particles for vaccination against Mycobacterium ulcerans disease. PLoS Negl Trop Dis. 2015;9(8):e0004011. DOI: 10.1371/journal.pntd.0004011

Bolz M, Ruggli N, Ruf M.T, Ricklin M.E, Zimmer G, Pluschke G. Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease. Trop Med Int Health, 2015;20(Suppl. 1):240. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

Bolz M. Prospects for the development of a subunit vaccine against Mycobacterium ulcerans diseases (Buruli ulcer). Basel: Univ. Basel, 2015. Doctoral Thesis, University of Basel, Faculty of Science DOI: 10.5451/unibas-006617575

Dreyer A, Röltgen K, Dangy J.P, Ruf M.T, Scherr N, Bolz M, Tobias N.J, Moes C, Vettiger A, Stinear T.P, Pluschke G. Identification of the Mycobacterium ulcerans protein MUL_3720 as a promising target for the development of a diagnostic test for Buruli ulcer. PLoS Negl Trop Dis. 2015;9(2):e0003477. DOI: 10.1371/journal.pntd.0003477

Bolz M, Ruggli N, Ruf M.T, Ricklin M.E, Zimmer G, Pluschke G. Experimental infection of the pig with Mycobacterium ulcerans: a novel model for studying the pathogenesis of Buruli ulcer disease. PLoS Negl Trop Dis. 2014;8(7):e2968. DOI: 10.1371/journal.pntd.0002968

Bratschi M.W, Bolz M, Grize L, Kerber S, Minyem J.C, Um Boock A, Yeboah-Manu D, Ruf M.T, Pluschke G. Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens. BMC Infect Dis. 2014;14:636. DOI: 10.1186/s12879-014-0636-7

Röltgen K, Bratschi M.W, Ross A, Aboagye S.Y, Ampah K.A, Bolz M, Andreoli A, Pritchard J, Minyem J.C, Noumen D, Koka E, Um Boock A, Yeboah-Manu D, Pluschke G. Late onset of the serological response against the 18 kDa small heat shock protein of Mycobacterium ulcerans in children. PLoS Negl Trop Dis. 2014;8(5):e2904. DOI: 10.1371/journal.pntd.0002904

Bratschi M.W, Bolz M, Minyem J.C, Grize L, Wantong F.G, Kerber S, Njih Tabah E, Ruf M.T, Mou F, Noumen D, Um Boock A, Pluschke G. Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the mape basin of cameroon. PLoS Negl Trop Dis. 2013;7(6):e2252. DOI: 10.1371/journal.pntd.0002252

Bratschi M.W, Njih Tabah E, Bolz M, Stucki D, Borrell S, Gagneux S, Noumen-Djeunga B, Junghanss T, Um Boock A, Pluschke G. A case of cutaneous tuberculosis in a Buruli ulcer-endemic area. PLoS Negl Trop Dis. 2012;6(8):e1751. DOI: 10.1371/journal.pntd.0001751

Tamborrini M, Bauer M, Bolz M, Maho A, Oberli M.A, Werz D.B, Schelling E, Zinsstag J, Seeberger P.H, Frey J, Pluschke G. Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface associated anthrose containing oligosaccharide. J Bacteriol. 2011;193(14):3506-3511. DOI: 10.1128/JB.00078-11